Signaling pathways
-
BA5918 IsoxicamSummary: Isoxicam is a potent, orally active non-steroidal anti-inflammatory agent for use in arthritis research. -
BA5919 NitroflurbiprofenSummary: A cyclooxygenase (COX) inhibitor. - BA5921 DehydroevodiamineSummary: Dehydroevodiamine is a quinazoline alkaloid isolated from Wuzhu.
- BA5922 HamaudolSummary: Hamaudol is a chromone.
- BA5923 MofezolacSummary: Mofezolac, a nonsteroidal anti-inflammatory drug (NSAID), is a selective, reversible and orally active inhibitor.
- BA5924 PelubiprofenSummary: Pelubiprofen is an orally active, nonsteroidal anti-inflammatory agent.
- BA5925 GW-406381Summary: A highly selective cyclooxygenase-2 inhibitor.
- BA5926 CimicoxibSummary: Cimicoxib (CX) is an orally effective selective (cyclooxygenase-2) inhibitor.
- BA5927 TazofeloneSummary: Tazofelone (LY213829) is a cyclooxygenase-II (COX-II) inhibitor.
- BA5928 SC57666Summary: SC57666 is a selective inhibitor.